Table 1.
Demographics of the study population collected at the end of the wet (Survey 1) and dry (Survey 2) seasons
| Characteristic | Survey 1: End of wet season (October 2012) |
Survey 2: End of dry season (June 2013) |
||||
|---|---|---|---|---|---|---|
| Total | Vea/Gowrie | Soe | Total | Vea/Gowrie | Soe | |
| Age groups* | ||||||
| All | 1,900 | 901 (47.4) | 999 (52.6) | 1,868 | 910 (48.7) | 958 (51.3) |
| 1–5 years | 354 (18.6) | 160 (17.8) | 194 (19.4) | 347 (18.6) | 162 (17.8) | 185 (19.3) |
| 6–10 years | 391 (20.6) | 183 (20.3) | 208 (20.8) | 397 (21.3) | 193 (21.2) | 204 (21.3) |
| 11–20 years | 405 (21.3) | 203 (22.5) | 202 (20.2) | 395 (21.1) | 207 (22.7) | 188 (19.6) |
| 21–39 years | 321 (16.9) | 151 (16.8) | 170 (17.0) | 310 (16.6) | 146 (16.0) | 164 (17.1) |
| ≥ 40 years | 429 (22.6) | 204 (22.6) | 225 (22.5) | 419 (22.4) | 202 (22.2) | 217 (22.7) |
| Gender* | ||||||
| Female | 1,016 (53.5) | 469 (52.1) | 547 (54.8) | 1,034 (55.4) | 494 (54.3) | 540 (56.4) |
| Male | 884 (46.5) | 432 (47.9) | 452 (45.2) | 834 (44.6) | 416 (45.7) | 418 (43.6) |
| Bed net usage previous night* | ||||||
| No | 210 (11.1) | 77 (8.5) | 133 (13.3) | 274 (14.7) | 98 (10.8) | 176 (18.4) |
| Yes | 1,690 (88.9) | 824 (91.5) | 866 (86.7) | 1,594 (85.3) | 812 (89.2) | 782 (81.6) |
| Antimalarial treatment (previous 2 weeks)* | ||||||
| No treatment | 1,109 (58.4) | 601 (66.7) | 508 (50.9) | 1,718 (92.0) | 866 (95.2) | 852 (88.9) |
| Treatment | 791 (41.6) | 300 (33.3) | 491 (49.1) | 150 (8.0) | 44 (4.8) | 106 (11.1) |
| Anemia status*† | ||||||
| Severe | 28 (1.5) | 17 (1.9) | 11 (1.1) | 9 (0.5) | 4 (0.4) | 5 (0.5) |
| Moderate | 439 (23.1) | 178 (19.8) | 261 (26.1) | 209 (11.3) | 93 (10.2) | 116 (12.3) |
| Mild | 420 (22.1) | 214 (23.8) | 206 (20.6) | 371 (20.1) | 179 (19.7) | 192 (20.5) |
| Nonanemic | 1,013 (53.3) | 492 (54.6) | 521 (52.2) | 1,257 (68.1) | 634 (69.7) | 623 (66.6) |
*
Data reflect no. (% [n/N]) of subjects.
†
For anemia status for Survey 2, there were 1,846 participants included in the analysis: exclusions were participants in Soe whose hemoglobin was not measured (N = 22) on the day the survey was conducted.